Johnson & Johnson MedTech to reinforce commitment to heart health awareness

Johnson & Johnson MedTech to reinforce commitment to heart health awareness

- Company unveiled ‘Get Smart About AFib’ global campaign on Atrial Fibrillation at the conference

Dubai, United Arab Emirates: In line with its commitment to raise awareness of cardiovascular disease and conditions in the Kingdom of Saudi Arabia, Johnson & Johnson MedTech participated in the 33rd Annual Conference of Saudi Heart Association [SHA] – one of the largest cardiac meetings in the middle east, held in Riyadh from 13 to 15 October 2022.

The company unveiled its ‘Get Smart About AFib’ نظم نبضك. احفظ قلبك global campaign at the conference in the presence of cardiac scientists, caregivers, and several cardiac working groups as part of its efforts to improve care and treatment for patients suffering from Atrial Fibrillation [AFib]. The campaign aims to raise awareness on the disease to help reduce risks.

The health campaign will specifically focus on supporting education and detection of the life-threatening AFib condition that impacts nearly 40 million people globally¹. AFib is the most common type of cardiac arrhythmia and nearly one in four adults, currently over the age of 40, across the globe, are at risk of developing it². According to statistics from Saudi Health Ministry, cardiovascular diseases account for 37 per cent of all deaths in